Nicolas D. Huyghe
European Society for Therapeutic Radiology and Oncology(BE)UCLouvain(BE)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Colorectal Cancer Treatments and Studies, HER2/EGFR in Cancer Research, Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics
Most-Cited Works
- → The Link between the Multiverse of Immune Microenvironments in Metastases and the Survival of Colorectal Cancer Patients(2018)281 cited
- → Immunotherapy with immune checkpoint inhibitors in colorectal cancer: what is the future beyond deficient mismatch-repair tumours?(2019)105 cited
- → Specific post-translational modifications of soluble tau protein distinguishes Alzheimer’s disease and primary tauopathies(2023)86 cited
- → Biomarkers of Response and Resistance to Immunotherapy in Microsatellite Stable Colorectal Cancer: Toward a New Personalized Medicine(2022)61 cited
- → Prognostic assessment of resected colorectal liver metastases integrating pathological features, RAS mutation and Immunoscore(2020)44 cited
- → Interim analysis of the AVETUXIRI Trial: Avelumab combined with cetuximab and irinotecan for treatment of refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC)—A proof of concept, open-label, nonrandomized phase IIa study.(2021)29 cited
- → 397P R-IMMUNE interim analysis: A phase Ib/II study to evaluate safety and efficacy of atezolizumab combined with radio-chemotherapy in a preoperative setting for patients with localized rectal cancer(2021)27 cited
- → Functional impacts of the ubiquitin–proteasome system on DNA damage recognition in global genome nucleotide excision repair(2020)25 cited
- → Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment(2023)11 cited
- → Interim analysis of the phase II AVETUXIRI trial: Avelumab combined with cetuximab and irinotecan for treatment of refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC).(2022)10 cited